Endocrine therapy response and 21-Gene expression assay for therapy guidance in HR+/HER2– early breast cancer.
27 Apr, 2022 | 07:41h | UTCEndocrine Therapy Response and 21-Gene Expression Assay for Therapy Guidance in HR+/HER2– Early Breast Cancer – Journal of Clinical Oncology (link to abstract – $ for full-text)
Commentary: Gene Score, Endocrine Response Can Guide Early Breast Cancer Therapy – MedPage Today (free registration required)